143 related articles for article (PubMed ID: 31106414)
1. From clinic to mechanism: Proteomics-based assessment of angiogenesis in adrenal pheochromocytoma.
Sun F; Zhuo R; Ma W; Yang D; Su T; Ye L; Xu D; Wang W
J Cell Physiol; 2019 Dec; 234(12):22057-22070. PubMed ID: 31106414
[TBL] [Abstract][Full Text] [Related]
2. The significance of angiogenesis in malignant pheochromocytomas.
Rooijens PP; de Krijger RR; Bonjer HJ; van der Ham F; Nigg AL; Bruining HA; Lamberts SW; van der Harst E
Endocr Pathol; 2004; 15(1):39-45. PubMed ID: 15067175
[TBL] [Abstract][Full Text] [Related]
3. HIF1A transcriptional regulation of COX4I2 impacts angiogenesis in pheochromocytoma.
Li X; Zhuo R; Mao Y; Fang C; Dai J; Ye L; Wang C; Sun F
Biochem Biophys Res Commun; 2024 Apr; 704():149638. PubMed ID: 38422899
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.
Osinga TE; Links TP; Dullaart RPF; Pacak K; van der Horst-Schrivers ANA; Kerstens MN; Kema IP
FASEB J; 2017 Jun; 31(6):2226-2240. PubMed ID: 28264974
[TBL] [Abstract][Full Text] [Related]
5. Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma.
Gao X; Yamazaki Y; Pecori A; Tezuka Y; Ono Y; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
Front Endocrinol (Lausanne); 2020; 11():587779. PubMed ID: 33244312
[TBL] [Abstract][Full Text] [Related]
6. Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.
Lee SE; Oh E; Lee B; Kim YJ; Oh DY; Jung K; Choi JS; Kim J; Kim SJ; Yang JW; An J; Oh YL; Choi YL
Oncotarget; 2016 Apr; 7(17):24141-53. PubMed ID: 27007161
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-101 in pheochromocytoma patients with SDHD mutation.
Zong L; Meng L; Shi R
Int J Clin Exp Pathol; 2015; 8(2):1545-54. PubMed ID: 25973039
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcome of laparoscopic surgery, including laparoendoscopic single-site surgery, for retroperitoneal paraganglioma compared with adrenal pheochromocytoma.
Hattori S; Miyajima A; Hirasawa Y; Kikuchi E; Kurihara I; Miyashita K; Shibata H; Nakagawa K; Oya M
J Endourol; 2014 Jun; 28(6):686-92. PubMed ID: 24499341
[TBL] [Abstract][Full Text] [Related]
9. COX4I2 is a novel biomarker of blood supply in adrenal tumors.
Mao Y; Ma W; Zhuo R; Ye L; Xu D; Wang W; Ning G; Sun F
Transl Androl Urol; 2021 Jul; 10(7):2899-2909. PubMed ID: 34430392
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
11. ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice.
Lai EW; Rodriguez OC; Aventian M; Cromelin C; Fricke ST; Martiniova L; Lubensky IA; Lisanti MP; Picard KL; Powers JF; Tischler AS; Pacak K; Albanese C
Cell Cycle; 2007 Aug; 6(15):1946-50. PubMed ID: 17671425
[TBL] [Abstract][Full Text] [Related]
12. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
Denorme M; Yon L; Roux C; Gonzalez BJ; Baudin E; Anouar Y; Dubessy C
Cancer Lett; 2014 Oct; 352(2):236-44. PubMed ID: 25016061
[TBL] [Abstract][Full Text] [Related]
13. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis in pheochromocytomas and paragangliomas.
Liu Q; Djuricin G; Staren ED; Gattuso P; Gould VE; Shen J; Saclarides T; Rubin DB; Prinz RA
Surgery; 1996 Dec; 120(6):938-42; discussion 942-3. PubMed ID: 8957477
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors.
Favier J; Plouin PF; Corvol P; Gasc JM
Am J Pathol; 2002 Oct; 161(4):1235-46. PubMed ID: 12368197
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
[TBL] [Abstract][Full Text] [Related]
17. Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma.
Ferreira CV; Siqueira DR; Romitti M; Ceolin L; Brasil BA; Meurer L; Capp C; Maia AL
Int J Mol Sci; 2014 Mar; 15(4):5323-36. PubMed ID: 24675699
[TBL] [Abstract][Full Text] [Related]
18. Survivin: a novel neuroendocrine marker for pheochromocytoma.
Koch CA; Vortmeyer AO; Diallo R; Poremba C; Giordano TJ; Sanders D; Bornstein SR; Chrousos GP; Pacak K
Eur J Endocrinol; 2002 Mar; 146(3):381-8. PubMed ID: 11888845
[TBL] [Abstract][Full Text] [Related]
19. Expression of Glutamine Metabolism-Related and Amino Acid Transporter Proteins in Adrenal Cortical Neoplasms and Pheochromocytomas.
Kim HM; Koo JS
Dis Markers; 2021; 2021():8850990. PubMed ID: 33505538
[TBL] [Abstract][Full Text] [Related]
20. VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome.
Salmenkivi K; Heikkilä P; Liu J; Haglund C; Arola J
APMIS; 2003 Apr; 111(4):458-64. PubMed ID: 12780519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
